About us

The LMB is responsible for many pioneering techniques, such as methods for determining the three-dimensional structures of proteins and other macromolecules, the sequencing of DNA and the development of monoclonal antibodies.

Our scientists tackle difficult, long-term research problems. At the same time they are encouraged to exploit their discoveries – through patents, licensing and business start-ups – helping to advance medical research and improve the UK’s economic competitiveness.

Insight on research

A protein quality control system for mislocalised proteins

Ubiquilins (green) and Huntington’s disease aggregates (red) in a cell

In order to function properly, many of the cell’s proteins need to be segregated to membrane-bound organelles and assembled into multi-protein complexes. Newly made proteins that fail to be localised or assembled properly must be promptly recognised by the cell and destroyed. These pathways of protein quality control are important because the accumulation of aberrant…

Development of effective immunity to infections is promoted by chromatin component

Nucleosomes-H33-IoR-may-16-crop

Effective immunity to infections requires the development of a diverse repertoire of antibodies. Antibody diversity is created through a process known as somatic hypermutation, which is the programmed mutation of specific sequences of DNA in the antibody genes. The introduction of mutations results in the production of antibodies that recognise and bind to different antigens,…

See more Insight on Research

Latest news

See more News

Latest publications


See more Publications